Cell And Gene Articles, App Notes, Case Studies, & White Papers

  1. Navigating The Biotech Landscape Amidst Covid-19 And Beyond 11/7/2023

    Access comprehensive insights and analysis for a deeper understanding of the biotech landscape, including optimism and challenges felt throughout 2023 and what the future could hold.

  2. 3D Cell Culture Reveals Undetectable Drug Efficacy In Traditional Systems 3/10/2025

    Drug discovery now targets cancer stem cells (CSCs) to achieve long-term tumor eradication, which moves beyond traditional chemotherapeutics. Discover an advanced screening platform that better predicts CSC inhibitor efficacy.

  3. Global Start-Up For Multinational Geographic Atrophy Trial 6/26/2025

    This partnership allowed a leading biopharmaceutical company to navigate the complexities of a Phase IIb study investigating a novel pegylated RNA adapter for geographic atrophy secondary to dry AMD.

  4. Sponsor Overcomes Hold And Steers Products Through Development 11/2/2023

    Uncover how a small-sized biotech company was able to resolve critical regulatory CMC deficiencies to meet FDA requirements.

  5. Simpler, Faster, Cheaper Advanced Therapy Manufacturing 2/3/2025

    Discover how TFDF-based perfusion technology boosts lentiviral vector production by over 10-fold, slashes costs, and accelerates the commercialization of CAR-T and other advanced cell therapies.

  6. Overcoming Rapid Growth Challenges With Process Liquid Preparation 5/10/2024

    With a helpful assessment and the right process liquid preparation services, the CDMO featured in this study was able to find a path toward meeting the surge in demand for a client's therapeutic .

  7. Optimize The Freezing Process With A Liquid Nitrogen Freezer 6/5/2024

    Take a closer look into research aimed at enhancing the cryogenic freezing process of the mammalian CHO-K1 cell line using a controlled-rate liquid nitrogen freezer.

  8. Evaluate The Effects Of A Xeno-Free Serum Replacement Media Supplementation 6/5/2024

    This study compares the impact of a specific Human Growth Factor Concentrate (hGFC) and fetal bovine serum (FBS) on the growth, expansion, and viability of MSCs.

  9. A Novel Approach To Improving AAV Titers 4/8/2025

    As demand for AAV-based therapies rises, optimizing production processes is essential. By utilizing existing technologies, tailored platforms, and optimized formulations, titers and productivity can be enhanced.

  10. Buffers And Process Liquids For Biopharmaceutical Production: Considerations For Scale-Up And Outsourcing 5/7/2024

    For small and midsize biopharmaceutical organizations, outsourcing buffer and process liquid preparation, quality testing, and storage could significantly streamline operations and reduce regulatory risk.